特发性血小板减少性紫癜接受皮质类固醇治疗后发生的卡波西肉瘤。
Kaposi sarcoma after corticosteroid therapy for idiopathic thrombocytopenic purpura.
作者信息
Choi Kwang Hyun, Byun Jae Ho, Lee Jun Young, Cho Baik Kee, Park Hyun Jeong
机构信息
Department of Dermatology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
出版信息
Ann Dermatol. 2009 Aug;21(3):297-9. doi: 10.5021/ad.2009.21.3.297. Epub 2009 Aug 31.
Abstract
Kaposi sarcoma (KS) is a multifocal vascular neoplasm most commonly seen in association with human immunodeficiency virus infection. However, KS has also been reported in patients treated with immunosuppressive agents. However, it is very rare to find KS in association with idiopathic thrombocytopenic purpura (ITP). Here we describe a 58-year-old male patient suffering from ITP treated with corticosteroid therapy who developed KS and present a review of the literature.
摘要
卡波西肉瘤（KS）是一种多灶性血管肿瘤，最常见于与人类免疫缺陷病毒感染相关的情况。然而，在接受免疫抑制剂治疗的患者中也有KS的报道。然而，卡波西肉瘤与特发性血小板减少性紫癜（ITP）相关的情况非常罕见。在此，我们描述一名58岁接受皮质类固醇治疗的ITP男性患者，该患者发生了卡波西肉瘤，并对相关文献进行综述。
相似文献
1
Kaposi sarcoma after corticosteroid therapy for idiopathic thrombocytopenic purpura.
Ann Dermatol. 2009 Aug;21(3):297-9. doi: 10.5021/ad.2009.21.3.297. Epub 2009 Aug 31.
2
[Kaposi's sarcoma developing during corticosteroid therapy in idiopathic thrombocytopenic purpura].
Rinsho Ketsueki. 1989 Aug;30(8):1310-3.
3
Concurrent thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in an HIV-positive patient: case report and review of the literature.
Am J Hematol. 1996 Jan;51(1):73-8. doi: 10.1002/(SICI)1096-8652(199601)51:1<73::AID-AJH12>3.0.CO;2-C.
4
Kaposi's sarcoma in a human immunodeficiency virus-negative patient treated with corticosteroid for idiopathic thrombocytopenic purpura.
Intern Med. 2003 May;42(5):448-9. doi: 10.2169/internalmedicine.42.448.
5
Refractory Thrombotic Thrombocytopenic Purpura in a patient with Kaposi sarcoma.
Transfus Apher Sci. 2019 Apr;58(2):187-189. doi: 10.1016/j.transci.2019.02.003. Epub 2019 Mar 19.
6
The appearance of Kaposi sarcoma during corticosteroid therapy.
Cancer. 1993 Sep 1;72(5):1779-83. doi: 10.1002/1097-0142(19930901)72:5<1779::aid-cncr2820720543>3.0.co;2-m.
7
Kaposi Sarcoma in an Immunocompetent Patient Treated With Paclitaxel.
Cureus. 2023 Jan 11;15(1):e33641. doi: 10.7759/cureus.33641. eCollection 2023 Jan.
8
Successful treatment with rituximab of refractory idiopathic thrombocytopenic purpura in a patient with Kabuki syndrome.
Int J Hematol. 2009 Sep;90(2):174-176. doi: 10.1007/s12185-009-0387-1. Epub 2009 Aug 7.
9
Successful treatment of a patient with refractory immune thrombocytopenic purpura in systemic lupus erythematosus with rituximab.
Immunol Med. 2019 Dec;42(4):185-188. doi: 10.1080/25785826.2019.1696644. Epub 2019 Dec 3.
10
Low-dose vincristine in the treatment of corticosteroid-refractory idiopathic thrombocytopenic purpura (ITP) in non-splenectomized patients.
Postgrad Med J. 1980 Oct;56(660):711-4. doi: 10.1136/pgmj.56.660.711.
引用本文的文献
1
A Review on Secondary Immune Thrombocytopenia in Malaysia.
Healthcare (Basel). 2021 Dec 26;10(1):38. doi: 10.3390/healthcare10010038.
2
Corticosteroid-induced Kaposi's Sarcoma Revealed by Severe Anemia: A Case Report and Literature Review.
Intern Med. 2020 Mar 1;59(5):625-631. doi: 10.2169/internalmedicine.3394-19. Epub 2019 Nov 8.
3
The Spectrum of Underlying Causes of Iatrogenic Kaposi's Sarcoma in a Large Series: A Retrospective Study.
Indian J Dermatol. 2019 Sep-Oct;64(5):392-399. doi: 10.4103/ijd.IJD_217_18.
4
Iatrogenic Kaposi's sarcoma caused by corticosteroids.
An Bras Dermatol. 2016 Nov-Dec;91(6):867-869. doi: 10.1590/abd1806-4841.20165772.
5
Role of radiotherapy in local control of non-AIDS associated Kaposi's sarcoma patients in Korea: a single institution experience.
Radiat Oncol J. 2012 Dec;30(4):153-7. doi: 10.3857/roj.2012.30.4.153. Epub 2012 Dec 31.
本文引用的文献
1
Kaposi's sarcoma in a human immunodeficiency virus-negative patient treated with corticosteroid for idiopathic thrombocytopenic purpura.
Intern Med. 2003 May;42(5):448-9. doi: 10.2169/internalmedicine.42.448.
2
Glucocorticoids inhibit apoptosis during fibrosarcoma development by transcriptionally activating Bcl-xL.
J Biol Chem. 2003 May 16;278(20):18022-9. doi: 10.1074/jbc.M301812200. Epub 2003 Mar 12.
3
Kaposi's sarcoma in two patients following low-dose corticosteroid treatment for rheumatological disease.
Rheumatology (Oxford). 2000 Nov;39(11):1294-6. doi: 10.1093/rheumatology/39.11.1294.
4
The appearance of Kaposi sarcoma during corticosteroid therapy.
Cancer. 1993 Sep 1;72(5):1779-83. doi: 10.1002/1097-0142(19930901)72:5<1779::aid-cncr2820720543>3.0.co;2-m.
5
Kaposi's sarcoma in an HIV-negative CLL patient as the cause of thrombocytopenia.
Ann Hematol. 1994 Jun;68(6):307-10. doi: 10.1007/BF01695038.
6
Nuclear binding of glucocorticoid receptors: relations between cytosol binding, activation and the biological response.
J Steroid Biochem. 1980 Jan;12:175-84. doi: 10.1016/0022-4731(80)90267-8.
7
Idiopathic thrombocytopenic purpura and Kaposi's sarcoma.
Proc R Soc Med. 1970 Jun;63(6):603-5. doi: 10.1177/003591577006300617.
8
[Kaposi's sarcoma developing during corticosteroid therapy in idiopathic thrombocytopenic purpura].
Rinsho Ketsueki. 1989 Aug;30(8):1310-3.
9
Rheumatoid arthritis, corticosteroid therapy and Kaposi's sarcoma: a coincidence? A case and review of literature.
Clin Rheumatol. 1992 Sep;11(3):432-5. doi: 10.1007/BF02207213.
10
Kaposi's sarcoma, rheumatoid arthritis and immunosuppressive and/or corticosteroid therapy.
J Rheumatol. 1992 Aug;19(8):1316-7.
Zotero 插件